Bruker Corporation (Nasdaq: BRKR) announces the acquisition of Dynamic Biosensors GmbH, a pioneering company known for its breakthroughs in biosensor development, which is based in Munich, Germany. This acquisition strengthens Bruker’s biophysical portfolio for the analysis of molecular interactions and kinetics, offering deeper insights into both inter-molecular and molecule-single cell interactions in drug discovery or basic research. Dynamic Biosensors (DBS) develops and markets innovative technologies for studying complex molecular interactions and kinetics, supporting drug discovery in the pharma and biotech industries, as well as in basic and medical research.
Read the full article: Bruker Acquires Dynamic Biosensors, a Pioneer of Single-Cell Interaction Cytometry Systems for Drug Discovery //
Source: https://www.businesswire.com/news/home/20241002811474/en/Bruker-Acquires-Dynamic-Biosensors-a-Pioneer-of-Single-Cell-Interaction-Cytometry-Systems-for-Drug-Discovery